Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study  Krupa.

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease.
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice Edward Balish, Thomas Warner The American Journal of Pathology.
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Work disability in inflammatory bowel disease
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe  Peter.
Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F
Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008  Peter Laszlo Lakatos,
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
National Guidelines for Nursing Delegation
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.
Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review  Doron Boltin, Zohar Levi, Marisa Halpern,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
YouTube® and inflammatory bowel disease
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M
Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants  T. Felekis, K.H. Katsanos, C.D. Zois,
Serum prohepcidin levels in chronic inflammatory bowel diseases
Charlotte de Bie, Angelika Kindermann, Johanna Escher 
N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard 
Endothelial function and cardiovascular risk in active inflammatory bowel diseases  Mariabeatrice Principi, Mario Mastrolonardo, Pietro Scicchitano, Michele.
Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease  Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim  Journal.
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years  May-Bente Bengtson, Camilla.
Public awareness of Crohn's disease and ulcerative colitis: A national survey  Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Is Early Placement Better in Alzheimer's Disease?
B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases  Danuta Owczarek,
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature  Dana Duricova, Johan Burisch,
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis  Thomas W. Lee, Michael.
Volume 132, Issue 7, Pages (June 2007)
Genetics and phenotypes in inflammatory bowel disease
Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease 
M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L
Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H
The usefulness of factor XIII levels in Crohn's disease
Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients  Marko Brinar, Séverine.
Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis  Niels Teich, Tobias Klugmann  Journal of.
Seth Lipka, Seymour Katz, Lev Ginzburg  Journal of Crohn's and Colitis 
Osteoporosis in inflammatory bowel disease
Pediatric pulmonary Crohn's disease: More frequent than expected
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation  Sjoerd F. Bakker,
Subrata Ghosh, Benjamin Pariente, Diane R
Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.
Does active smoking really influence the course of Crohn's disease
Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function  Ulf Hindorf, Malin Lindqvist.
Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms  Mariëlle.
Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis  S.D. McLaughlin, A. Culkin,
Bowel sonography in occlusive Crohn's disease
The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China  Yue Li, Li-fan Zhang, Xiao-qing.
Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors  Anilga Moradkhani, Linda.
Volume 143, Issue 5, Pages (November 2012)
Changes in Fatigue Over 2 Years Are Associated With Activity of Inflammatory Bowel Disease and Psychological Factors  Lesley A. Graff, Ian Clara, John.
Toward Improved Understanding of a Potential Association between Isotretinoin and Inflammatory Bowel Disease  Alisa N. Femia, Ruth Ann Vleugels  Journal.
Volume 151, Issue 1, Pages (July 2016)
Table of contents The Journal for Nurse Practitioners
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Table of contents The Journal for Nurse Practitioners
American Journal of Kidney Diseases
Direct Observation of Residents: A Model for an Assessment System
Seasonal variation in flares of inflammatory bowel disease
Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F
Presentation transcript:

Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study  Krupa Krishnaprasad, Jane M. Andrews, Ian C. Lawrance, Timothy Florin, Richard B. Gearry, Rupert W.L. Leong, Gillian Mahy, Peter Bampton, Ruth Prosser, Peta Leach, Laurie Chitti, Charles Cock, Rachel Grafton, Anthony R. Croft, Sharon Cooke, James D. Doecke, Graham L. Radford-Smith  Journal of Crohn's and Colitis  Volume 6, Issue 3, Pages 287-293 (April 2012) DOI: 10.1016/j.crohns.2011.08.016 Copyright © 2011 Terms and Conditions

Figure 1 Summary of Montreal Classification of Crohn's Disease. Journal of Crohn's and Colitis 2012 6, 287-293DOI: (10.1016/j.crohns.2011.08.016) Copyright © 2011 Terms and Conditions

Figure 2 Study participants and member centres of ANZIBDC (Australia and New Zealand Inflammatory Bowel Disease Consortium). Journal of Crohn's and Colitis 2012 6, 287-293DOI: (10.1016/j.crohns.2011.08.016) Copyright © 2011 Terms and Conditions

Figure 3 Montreal Classification of patient cohort at baseline, n=35 (example from one of the practitioner's assessments). Journal of Crohn's and Colitis 2012 6, 287-293DOI: (10.1016/j.crohns.2011.08.016) Copyright © 2011 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.